NYSE American: VNRX

Volitionrx Ltd. (VNRX)

Volitionrx Ltd. is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE American under the ticker VNRX. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
VNRX
Exchange
NYSE American
SEC CIK
93314
Official filings
SEC EDGAR

Research VNRX

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Volitionrx Ltd.'s stock ticker?

Volitionrx Ltd. trades under the ticker symbol VNRX on NYSE American. Its SEC Central Index Key (CIK) is 93314.

Where can I read Volitionrx Ltd.'s SEC filings?

The VNRX SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Volitionrx Ltd. has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze VNRX's financial statements?

The VNRX Financials page shows Volitionrx Ltd.'s income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does VNRX compare with its peers and the market?

The VNRX Peer Comparison page lines Volitionrx Ltd. up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.